Proenkephalin mRNA levels in rat striatum are increased and decreased, respectively, by selective D2 and D1 dopamine receptor antagonists
- 29 April 1991
- journal article
- Published by Elsevier in Neuroscience Letters
- Vol. 125 (2) , 201-204
- https://doi.org/10.1016/0304-3940(91)90028-r
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Chronic Treatment of Rats with SCH‐23390 or Raclopride Does Not Affect the Concentrations of DARPP‐32 or Its mRNA in Dopamine‐Innervated Brain RegionsJournal of Neurochemistry, 1990
- Effect of Chronic Typical and Atypical Neuroleptic Treatment on Proenkephalin mRNA Levels in the Striatum and Nucleus Accumbens of the RatJournal of Neurochemistry, 1990
- D1 and D2 Dopaminergic Regulation of Acetylcholine Release from Striata of Freely Moving RatsJournal of Neurochemistry, 1990
- Differential modulation of striatonigral dynorphin and enkephalin by dopamine receptor subtypesBrain Research, 1990
- Neuronal localisation of neuropeptide Y gene expression in rat brainJournal of Comparative Neurology, 1989
- Localization of striatal opioid gene expression, and its modulation by the mesostriatal dopamine pathway: An in situ hybridization studyJournal of Molecular Neuroscience, 1989
- D1 and D2 dopamine agonist synergism: separate sites of action?Trends in Pharmacological Sciences, 1987
- Parkinson's disease affects differently Met5- and Leu5-enkephalin in the human brainBrain Research, 1983
- Regulation of methionine-enkephalin precursor messenger RNA in rat striatum by haloperidol and lithiumBiochemical and Biophysical Research Communications, 1983
- Selective binding of YM-09151-2, a new potent neuroleptic, to D2-dopaminergic receptors.The Japanese Journal of Pharmacology, 1983